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Towards water‑soluble [60]
fullerenes for the delivery of siRNA 
in a prostate cancer model
Julia Korzuch1,6, Monika Rak2,6, Katarzyna Balin3, Maciej Zubko4,5, Olga Głowacka2, 
Mateusz Dulski4, Robert Musioł1, Zbigniew Madeja2 & Maciej Serda1*
This paper presents two water‑soluble fullerene nanomaterials  (HexakisaminoC60 and 
 monoglucosamineC60, which is called here JK39) that were developed and synthesized as non‑
viral siRNA transfection nanosystems. The developed two‑step Bingel–Hirsch reaction enables 
the chemical modification of the fullerene scaffold with the desired bioactive fragments such as 
d‑glucosamine while keeping the crucial positive charged ethylenediamine based malonate. The 
ESI–MS and 13C‑NMR analyses of JK39 confirmed its high  Th symmetry, while X‑ray photoelectron 
spectroscopy revealed the presence of nitrogen and oxygen‑containing C–O or C–N bonds. The 
efficiency of both fullerenes as siRNA vehicles was tested in vitro using the prostate cancer cell line 
DU145 expressing the GFP protein. The  HexakisaminoC60 fullerene was an efficient siRNA transfection 
agent, and decreased the GFP fluorescence signal significantly in the DU145 cells. Surprisingly, 
the glycofullerene JK39 was inactive in the transfection experiments, probably due to its high zeta 
potential and the formation of an extremely stable complex with siRNA.
Nanotechnology has changed traditional medicinal chemistry, by enabling the development of small molecular 
drugs with targeted  nanotherapeutics1. The central premise of medical chemistry is that a specific small mol-
ecule can bind to the desired enzyme or receptor, which results in a specific therapeutic effect. The aforemen-
tioned inhibition process can also be achieved using nucleic acid therapies including a technique called RNA 
interference (Nobel Prize 2006) in the presence of engineered nanomaterials used as transfection  agents2,3. An 
efficient transfection agent must deliver the targeted siRNA into the cytoplasm where it degrades the targeted 
mRNA after binding to the argonaute proteins (AGO) and the further formation of the RNA-induced silencing 
complex (RISC)4. Recently, the FDA has approved an siRNA-based drug (lipid nanoparticles, patisiran) to treat 
transthyretin-mediated  amyloidosis5. Due to increased interest in the nanomedical approaches in molecular 
biology, the interactions of nucleic acids and carbon nanomaterials have been thoroughly studied and discussed, 
mainly focusing on the interactions of the DNA-carbon nanotubes/cationic  fullerenes6,7. The use of [60]fullerene 
hexakisadducts as DNA transfection agents was previously described in case of multivalent cationic fullerenes 
and polycationic fullerenes, which formed a stable complexes with DNA plasmids with minimal cytotoxicity 
in mammalian  cells8–10. Although the interaction of the cationic fullerenes with DNA is well presented even in 
murine models, the siRNA transfection techniques have mainly been developed for only one derivative, TPFE 
(tetra-piperazino-[60]fullerene epoxide)11, which forms a stable 7 nm micelle, but has limited options for its 
further chemical functionalization or the addition of targeting groups or ligands for biorthogonal/click chemistry. 
Furthermore, the main advantages of fullerene-based transfection agents over cationic lipids are the high water-
solubility, the ability to cross biological membranes, low cytotoxicity and a high synthetic accessibility allowing 
additional options for bioconjugation with desired drugs in engineered nanomaterials. Moreover, it has been 
proven that TPFE is non-toxic and is effective for lung-targeted in vivo siRNA delivery, which is based on the 
formation of the micrometer-sized TPFE–siRNA–serum protein complexes, which could be a stabilization fac-
tor for relatively unstable siRNA under physiological  conditions12. Studies performed by Wang et al. described a 
fullerene-ethylenediamine modified dextran hybrid  (C60-Dex-NH2) as an efficient siRNA transfection agent when 
they evaluated it in the human breast cancer cell line MDA-MB-231, which could be photo-activated and could 
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destroy the endo-lysosomal membranes via a controllable generation of  ROS13. Simultaneously, the interactions 
of carbon nanomaterials with biological fluids are crucial factors that determine their cellular fate and further 
tissue  targeting14,15. Experimental and computational studies have been performed to describe the formation 
of complexes between the water-soluble carboxylated fullerenes and serum albumins and other proteins such 
as lysosome and the serine  proteinases16,17. Our previous studies showed that the protein corona is formed on 
the surface of glycofullerenes and modulates their inhibitory activity, however its detailed composition is still 
 unknown18. Due to nanoparticle zeta-potentials influence on the formation and composition of the protein 
corona, it was observed that in positively charged nanoparticles after their complexation with the plasma proteins, 
the complex’s final zeta potential  decreases19.
Herein a facile methodology for the synthesis of highly water-soluble [60]fullerene hexakisadducts is pre-
sented using the Bingel-Hirsch synthetic approach to modify the buckyball scaffold. Our robust protocol was 
used to create two highly functionalized Th symmetrical fullerene nanomaterials including  monoglucosamineC60 
which is called here a JK39 compound with a d-glucosamine’s fragment. The rationale behind this approach was 
to increase the interactions of the nucleic acids with a sugar fragment as has been described for the chitosan-based 
transfection  agents20. The additional advantage of fullerene hexakisadducts is that they limit the occurrence of 
several regioisomers, simplify of the purification process and increase water-solubility in contrast to the fullerene 
monoadducts, which is particularly useful in biological  experiments21,22. During the designing step, we kept 
in mind that the glycofullerenes that we previously reported on, could localize in the nuclear envelope- which 
could be a beneficial property for the transfection  process23. We previously described  HexakisaminoC60 as being 
a non-toxic photosensitizer that could be used to generate reactive oxygen species as described for the treatment 
non-melanoma skin  cancer24. The engineered water-soluble aminofullerenes  HexakisaminoC60 and JK39 were 
designed as dual-acting nanotherapeutics, which degrade a targeted mRNA in a sequence-specific manner that 
might have a potential additional photodynamic activity. Considering the interactions of fullerenes with serum 
albumins, the transfection experiments were conducted in a FBS-containing medium to test the ability of the 
synthesized carbon nanomaterials to transfect the desired siRNA. We selected Lipofectamine 3000 because it is 
a modern transfection agent that is commonly used in molecular biological  experiments25.
Methods
Materials. All of the compounds that were used reagent grade or better, and the solvents were used as 
they were received unless otherwise specified. The following reagents were used as received:  C60 (99.5 + %, SES 
Research, U.S.A.), d-glucosamine hydrochloride (Sigma Aldrich), DBU (1,8-diaza-bicyclo[5.4.0]undec-7-ene, 
Sigma Aldrich), ethyl hydrogen malonate (Sigma Aldrich),  CBr4 (Sigma Aldrich) and DIC. The following rea-
gents: acetic anhydride (Fisher), pyridine (Sigma Aldrich), and DMF (Sigma Aldrich) were prepared accord-
ing to the procedures in the literature, distilling them with calcium hydride and were then used immediately. 
The Lipofectamine 3000, which was used as the control siRNA transfection agent, was obtained from Thermo 
Fisher Scientific (U.S.A.). For the in vitro experiments we have used the human prostate cancer (DU145) cell 
line (American Type Culture Collection, Rockville, U.S.A.), 24-well plates (Corning;  Falcon®), a DMEM F12 
Ham medium (Sigma-Aldrich, St.Louis, MO, USA), fetal bovine serum (FBS; Gibco), Penicillin–Streptomycin 
(Sigma-Aldrich, St.Louis, MO, USA), PTAI-11 (trimethyl undecaprenyl ammonium iodide; Collection of Poly-
prenols, Institute of Biochemistry and Biophysics PAS, Warsaw, Poland; PTAI-11 is patented (No. 231158, Pol-
ish Patent Office 2019; No. 230096, Polish Patent Office 2018, No. 211824, Polish Patent Office 2012) and there 
is a patent application pending (No. PCT/PL2015/000093, WO/2016/032348, Polish Patent Office, European 
Patent Office), DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; Sigma-Aldrich, St.Louis, MO, USA), 
DC-cholesterol (3ß-[N-(N’,N’-dimethylaminoethane)-carbamoyl]cholesterol hydrochloride; Sigma-Aldrich, 
St.Louis, MO, USA).
The nuclear magnetic resonance spectra were measured on a Bruker Avance III 500 MHz NMR Spectrometer 
with TMS as the internal standard. The MS spectra were collected using an electrospray ionization time-of-flight 
(ESI-microTOF) mass spectrometer from Bruker Daltonics Inc (U.S.A.). The high-resolution mass spectrometry 
was carried out on the ESI-Q-TOF maXis impact (Bruker Daltonics Inc, U.S.A.). The purity of all the compounds 
was assessed using an Agilent1260 HPLC equipped with a DAAD detector at 260 nm, RP-column: Eclipse 
plus  C18 (3.5 μm); flow 0.5 mL/min. The Fourier transform infrared (FTIR) measurements were taken using 
an Agilent Cary 640 FTIR spectrometer, that was equipped with a common source and a DTGS Peltier-cooled 
detector. The fullerene powders were measured using ATR diamond accessory   in the 400–4000  cm−1 range. 
The spectrum was recorded at 32 accumulations and at a spectral resolution of 4  cm−1. The dynamic light scat-
tering and zeta potentials for the fullerene nanomaterials and their complexes with siRNA were measured using 
Zetasizer Nano (Malvern Panalytical Ltd, UK). The transmission electron microscopy (TEM) observations were 
performed using a JEOL high resolution (HR-TEM) JEM 3010 microscope operating at a 300 kV accelerating 
voltage, that was equipped with a Gatan 2 k × 2 k Orius™ 833SC200D CCD camera. The chemical analysis of the 
surface of fullerenes was performed using the X-ray photoelectron spectroscopy (XPS) technique. The X-ray 
Photoelectron Spectroscopy measurements were taken using a Physical Electronic XPS spectrometer (Physical 
Electronics PHI 5700, Chanhassen, MN, U.S.A.). Monochromatic Al Kα radiation (1486 eV) was used to excite 
the photoelectrons from the surface of fullerenes. The photoemission spectra were collected in a wide binding 
energy range (− 2 to 1400 eV) and in the characteristic photoemission lines binding energy ranges of carbon, 
oxygen, nitrogen, and fluorine which was detected on samples’ surface. The analysis was carried out using PHI 
MultiPak (v.9.6.0.1, ULVAC PHI, Chigasaki, Japan) software. The EGFP silencing efficiency was evaluated with 
an OLYMPUS IX81 (Olympus) fluorescence microscope and a  Guava® easyCyte 8 flow cytometer (Luminex, 
Austin, TX, USA), at a 488 nm laser excitation. The percentage of GFP-positive cells was analyzed using InCyte 
software ver. 3.3 (Luminex, Austin, TX, USA).
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Synthesis of fullerene JK39 and malonic acid ligands for Bingel–Hirsch reaction. Our group 
previously described the  HexakisaminoC60 synthetic  protocol24. The robust approach for obtaining fullerene 
nanomaterial JK39 is depicted in Scheme S1 in the Supporting Information, and includes additional spectro-
scopic data. The synthesis of the [60]fullerene monoadduct (5), as well as its malonic acid precursor that con-
tains the d-Glucosamine unit (4), were also previously described by our  group23.
Ethylenediamine (15 mL; 0.25 mol) was dissolved in chloroform and cooled to 0 °C followed by the dropwise 
addition of 125 mL of a chloroform solution of di-tert-butyl bicarbonate (5.46 g; 0.025 mol) over three hours. 
Then, the reaction mixture was allowed to reach room temperature after which it was stirred for an additional 
16 h. After that time, the solution was washed six times, with 200 mL of DI water and four times with 200 mL 
of brine. The organic phases were dried over  MgSO4 and evaporated under reduced pressure. The final product 
was obtained as a colorless oil of N-Boc-protected ethylenediamine (1) with a 45% yield. The N-Boc-1,2-diami-
noethane (1 g; 6.2 mmol) was dissolved in 50 mL of methanol, and then dimethylmalonate (0.39 g; 2.95 mmol) 
was added dropwise. The reaction mixture was refluxed for three hours and then stirred for an additional 72 h 
at room temperature. After that time, the methanol was evaporated in vacuo. The final product was purified by 
the initial extraction (DCM/H2O) followed by column chromatography (DCM:MeOH, 20:1). The final product 
(2) was obtained as a sticky off-white gum with13% yield.
The glycofullerene monoadduct (5) (45.2 mg; 0.0365 mmol) was dissolved in 10 mL of dichloromethane and 
100 mL of toluene. The mixture was stirring for 15 min. Then the N-Boc-diethylamine malonate (142 mg; 0.365 
mmol) and  CBr4 (241.6 mg; 0.73 mmol) were dissolved in 10 mL of DCM that had been added to the fullerene 
solution. In the next step, DBU (66.7 mg; 0.438 mmol) was dissolved in 3 mL of dichloromethane, and 0.5 mL of 
the base was added to the solution for six hours. After all of the DBU was added, the reaction mixture was stirred 
at room temperature, for an additional 48 h, during which the color of the solution changed from red-brown to 
orange. The product was purified using a flash column in the gradient conditions (DCM, DCM: MeOH 10:1 to 
5:1). The  C60 hexakisadduct (6) structure which had a  Th symmetry was confirmed using 13C-NMR spectroscopy 
and mass spectrometry. To obtain a water-soluble fullerene derivative (7), the hexakisadduct was dissolved in 
10 mL of DCM, and 20% trifluoroacetic acid was added. The reaction was stirred at room temperature for 10 
days, during which two phases appeared in the solution. The water phase was collected, evaporated in vacuo and 
purified on centrifugal membranes using a 1 kDa filter membrane (Pall Corporation, U.S.A.). The top layer of the 
membrane was washed five times, with 15 mL of distilled water. Subsequently, the [60]fullerene nanomaterial 
was frozen at − 20 °C and freeze-dried. The final product was obtained as a brown solid with a 30% yield and was 
stored in a laboratory freezer at − 20 °C. The hexakisadduct (7) was characterized using NMR spectroscopy and 
infrared spectroscopy, and the structure was confirmed using ESI mass spectrometry.
Imaging the siRNA‑aminofullerene complexes using transmission electron microscopy. The 
TEM measurements that are presented in Figs. 3A,B and S8 were obtained using a JEOL high resolution (HR-
TEM) JEM 3010 microscope operating at a 300 kV accelerating voltage. The samples of the fullerene–siRNA 
complexes (20 µL of a desired solutions in nuclease free water, R = 70; 0.45 µg siRNA GFP and 37.5 µg of fullerene 
nanomaterial) were deposited on a copper grid with a holey carbon amorphous film under air and then dried at 
room temperature for 24 h.
siRNA transfection using the fullerene nanomaterials. The human prostate cancer (DU145) cell 
line was obtained from the American Type Culture Collection (Rockville, U.S.A.), nr HTB-81. The DU145 cells 
were seeded into the wells of a 24-well plate at a density of 5 ×  104 and cultivated for 24 h in a DMEM F12 
Ham medium with 10% FBS without antibiotics. The [60]fullerene nanomaterials and siRNA were suspended in 
nuclease-free water at pH 7. Next, they were mixed at a 1:1 (v:v) ratio and incubated for 30 min at room tempera-
ture. After incubation, the mixture was added to the wells with the cells that contained the FBS-supplemented 
medium (final FBS concentration—5%). A 0.45 µg/well of siRNA GFP (Sigma Aldrich) was used with 37.5 µg of 
 HeksakisaminoC60, 37.5 µg of JK39, or 1.5 µL of  Lipofectamine® 3000. After five hour incubation 300 µL of the 
medium that had been supplemented with 20% of FBS and antibiotics (Penicillin–Streptomycin [200U–0.2 mg/
mL]). The mixture of PTAI-11 (trimethylundekaprenylammonium iodide; Collection of Polyprenols, Institute of 
Biochemistry and Biophysics PAS, Warsaw, Poland) + DOPE (1,2-dioleoyl-sn-glycero-3-phosphoethanolamine; 
Sigma Aldrich) + DC-cholesterol (3ß-[N-(N′,N′-dimethylaminoethane)-carbamoyl]cholesterol hydrochloride; 
Sigma Aldrich) at a 1:1:1 molar ratio in 3 µg of lipids was used 24 h after the siRNA had been introduced into the 
transfected cells with 2.7 µg of pEGFP-C1 plasmid as was previously  described26,27. To summarize, the experi-
mental steps were: day 1—plating cells; day 2—transfection with siRNA using fullerenes or  Lipofectamine® 3000; 
day 3—transfection with the pEGFP-C1 plasmid using PTAI-11 + DOPE + DC-cholesterol and day 4—evaluat-
ing the efficiency of EGFP silencing.
Results and discussion
The procedure for synthesizing  HexakisaminoC60 as well as its biophysical properties were published earlier, when 
investigating its photodynamic activity in the non-melanoma skin cancer  model24. The fullerene nanomaterial 
JK39 was obtained in a time-controlled two-step Bingel–Hirsch reaction (for the synthetic protocol, see the Sup-
porting Information Scheme S1), in which a peracyleted d-glucosamine fullerene monoadduct (5) was further 
modified in a second Bingel-Hirsch reaction with Boc-protected malonate (2) its high-resolution ESI spectrum 
is presented in Fig. S4. In general, the Boc protection on aminomalonate was more useful in the Bingel-Hirsch 
reaction in terms of the general yields and purification procedure than a previously used trityl function. As a 
result,  Th-symmetrical hexakisadduct (6) was created, whose structure was confirmed by the presence of two 
fullerene  sp2 signals at δ = 146 and 141 ppm along with an  sp3 signal at δ = 69 ppm in the 13C-NMR spectrum of 
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(6) (Fig. S2). Additionally, one could also observe three characteristic signals for different types of NH groups, 
which are presented between 8.20 and 7.30 ppm in 1H-NMR spectrum (Fig. S1) of fullerene nanomaterial (6). 
After the hydrolysis of [60]fullerene derivative (6) a highly water-soluble fullerene nanomaterial (7) was created, 
and its structure was studied using 13C-NMR spectroscopy. The strongest signals in 13C-NMR of fullerene nano-
material (7) are those connected with TFA counter anion signals (both quartets are located around 162 and 115 
ppm, Fig. S3) as well as the methylene groups in ethylenediamine fragments (NH–CH2CH2NH), located at 38 
and 37 ppm, which are depicted in Fig. S3. Due to the limits of our ESI–MS detector (3000 Da), we were not able 
to measure the molecular peak of the protected fullerene nanomaterial (6) which had a molecular mass at 3109 
Da; however, it was possible to detect signals from its fragmentation (Fig. S5). The peak at 2685 Da resulted from 
the fragmentation of D-glucosamine malonate (M = 459 Da) from the parent structure with the addition of two 
water molecules. In contrast, the peak at 2297 Da corresponded to the fragmental structure without an acetylated 
d-glucosamine malonate unit, and one Boc-protected aminomalonate (M = 388 Da), which was presented as an 
adduct with two water molecules. In the next step in our synthetic protocol, the acetyl and Boc protection were 
removed from the fullerene nanomaterial (6) via a TFA hydrolysis, which was followed by further membrane 
dialysis, to form the final water-soluble JK39, which was further characterized using the NMR, FTIR, and XPS 
techniques with additional measurements of its size (DLS) and zeta potential.
The ESI-mass spectrum of a water-soluble fullerene is depicted in Fig. 2B. We were not able to directly detect 
its molecular peak (M = 1941 Da) due to its polycationic nature, although the spectrum did show a huge signal 
at 1038 Da, which corresponded to the double-charged cationic form of fullerene (7) [M +  3Na]2+.
The analysis of the infrared spectrum of JK39 is very similar to previously published  HexakisaminoC60 and 
should be performed by considering two spectral regions, firstly (1) 2250–3800  cm−1 and secondly, (2) 400–1900 
 cm−1 (Fig. 2A)24. According to this division, for both compounds region 1 is determined by the presence of the 
overlapping signals that had originated from the symmetric and asymmetric stretching modes of ν(CHx), and 
the ammonium cations containing ν(–CH2NHx+) (x = 2, 3)28. As a result of the introduction of the d-glucosamine 
fragment, an additional band at 3246  cm−1 can be explained by the presence of amine ν(NH), and it is worth 
noting that its position is linked to the presence of intra- or intermolecular interactions with hydroxyl  groups29. 
It is also interesting that the character of the band arrangement within region 1 in both compounds indicated 
a considerable distribution and high number of H-bonds with different donor–acceptor bond lengths. Unfor-
tunately, it was not easy to interpret and analyze the signal of the hydroxyl groups due to the high complexity 
of the spectrum, e.g. there was an increase in the intensity of the signal of JK39 above 3300  cm−1, which may 
indicate the presence of the hydroxyl groups as a result of the introduction of the glucosamine fragment. In 
turn, interpreting of the bands from region 2 was much more complicated due to the higher complexity of the 
molecular vibration. However, two bands at around 1665  cm−1 and 1527  cm−1 referred to the asymmetric and 
symmetric deformation vibration of ammonium cation, while the shoulders that were observed close to those 
two maxima but that were located at lower wavenumbers, are related to the vibration of the ammonium cation. 
The literature and previously reported data for  HexakisaminoC60 that suggested that the position of the band at 
1665  cm−1 might also be explained by taking into account the stretching vibration of carbonyl modes due to the 
occurrence of the β-diketone  structure24,30, or due to the high dynamicity of the system through the formation 
of hydrogen bonds which shifted the carbonyl band maximum into lower wavenumbers. In turn, the presence of 
a less intense band around 1800  cm−1 might be explained through the presence of N-protonated amide moiety, 
which is unusual due to well-known favorable O-protonation process. However, it was previously discussed in 
the literature that some amides and peptides are N-protonated, especially in case of strained amides, but also for 
peptides with electron donating groups and alfa-effects31–33. Other bands at the maxima around 1430, 1180, and 
1120  cm−1 might respectively be linked to the deformational modes of the ethylenediamine groups, the rocking 
vibration of the ammonium cation or the skeletal vibration of the alkane chain and deformational modes of the 
methylene groups. The presence of sugar-based malonate was also reflected in the occurrence of low intense 
bands at 1369, 1285, and 1039  cm−1 due to the C–O–C vibration within the pyranose ring and the deformational 
modes of –CH2CH3 chain.
The local environment detected on the fullerene surface elements was examined using the XPS technique. 
Based on the analysis of the XPS survey spectra, several elements were detected on the surface of both fuller-
ene nanomaterials. The chemical composition and calculated atomic and weight concentrations are combined 
for both fullerenes in Table S1 (see Supporting Information). Elements with an atomic concentration below 
one atomic percentage, such as Si, S, Na, Cl, and Br can be treated as contaminants. An analysis of the main 
components of the examined samples (C, O, N, F) indicated some variations in the atomic concentration and, 
consequently, in the relative ratio of the individual components. The most pronounced differences are presented 
in the amount of the detected carbon and nitrogen as both of the fullerene nanomaterials have the same eth-
ylenediamine core with the main difference in the d-glucosamine unit (Fig. 1). The chemical state for carbon, 
oxygen, nitrogen, and fluorine was determined by analyzing the high-resolution spectra of the C1s, O1s, F1s, 
and N1s photoemission lines. It was revealed that for a particular element, the presence of several different 
chemical states was related to the specific chemical bonding with the surrounding elements. The analysis of the 
main component of the both samples—carbon indicated that carbon existed in several different chemical states 
(see deconvoluted C1s line in Fig. 2C). The chemical state with the lowest binding energy (282.42 eV for sample 
JK39 and 282.58 eV for the  HexakisaminoC60) was related to the occurrence of silicone contamination. The most 
pronounced peak in the spectra of both samples was located at 284.82 eV and was related to the presence of C–H 
or C–C  bonds34. Interestingly, oxygen and nitrogen containing groups C–O or C–N (at 287.10 eV) were detected 
for both  samples35,36, whereas the presence of typical carbonyl group (C=O) (288.18 eV) was only detected for 
fullerene  JK3937,38. For the  HexakisaminoC60 fullerene, the peak at 288.5 eV was assigned to the O=C–OH bond, 
which could be also correlated to the presence of  CF3COO−  counterion38. The C–F (286.3 for JK39, and 286.6 
eV for  HexakisaminoC60) bond and –CF3 fragment of trifluoroacetic acid (687.8 eV for JK39 and 687.9 eV for 
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 HexakisaminoC60) were identified through the F1s deconvolution presented in Fig. S939. The O1s line (Supporting 
Information, Fig. S9)  that indicated a carbon–oxygen bond; weakly adsorbed oxygen  (O2/OH−) were detected 
at ~ 530.3 eV, C=O (carbonyl slightly below 532 eV), and O–C=O at around 533.3  eV40,41. The deconvoluted 
N1s line (see Fig. 2C) indicated the presence of four components; the most pronounced component at 399.6 eV 
was assigned to the C–N36 or N–(C=O)–  bonds42, the one at 398.0 eV to basic nitrogen(pyridinic type), and the 
chemical state at 401.4 eV to quaternary  N43. Assuming that some of the nitrogen in the 398 eV bonding energy 
state could come from N-protonated amide fragment, the increased amount that was observed for sample JK39 
(see the green line in Fig. 2C, for sample JK39, it was 22% of all of the nitrogen, for  HexakisaminoC60—13%) 
could confirm the structure of sample JK39 with nitrogen attached to pyranose ring. We also calculated pKa 
values of all nitrogen atoms in our malonate substrates which are depicted in Fig. S10. In case of d-glucosamine 
containing malonate  pKa of the nitrogen is 19.3, while the ethylenediamine-based malonate has to pKa one for 
amine (10.2) and amide 19.5.
Based on our previous studies with water-soluble fullerenes and kinetic experiments on fullerene  C60ser that 
were conducted Wilson’s group, we postulated that the synthesized fullerene nanomaterials would form smaller 
and larger aggregates in a water solution, that are in constant  equilibrium18,44. They can disaggregate when they 
are exposed to a higher ionic strength (salt addition), organic solvents, and the adsorption of the protein corona 
on the surface of  fullerene18. At a concentration of 0.1 mg/mL,  HexakisaminoC60 forms aggregated at 100 nm 
(PDI = 0.2) with a zeta potential at + 28.6  mV24, while the fullerene derivative JK39 formed two subpopulations 
of aggregates at 134 and 599 nm (PDI = 0.365) also with two different values of the zeta potential at + 54 and + 90 
mV (Figs. S6, S7, Supporting Information). The presence of two signals in the zeta potential measurement of JK39 
might be caused by the considerable polydispersity of the fullerene nanomaterial and could confirm its lower 
stability. Additionally, the studies performed by Deryabin et al. on ten different fullerene derivatives demonstrated 
an obvious relationship between the zeta potentials of the functionalized [60]fullerene aggregates and their size 
in salt-free  aqueous45. Besides, nanoparticles with a positive zeta potential have a long-circulating half-life due 
to the absorption of the protein corona and can form electrostatic complexes with RNA which is crucial when 
developing siRNA transfection  agents46. When developing efficient fullerene nanomaterial transfection agents, 
certain conditions must be met. Firstly, the engineered fullerene nanomaterials should be able to form a stable 
complex with the desired sequence of siRNA, and that complex must deliver the RNA to the cytosol, thus protect-
ing it from being degraded by  nucleases47. On the other hand, the complex that is formed between the RNA and 
cationic fullerene should not be too stable—the desired siRNA has to cleave from the complex and perform an 
endosomal escape and intracellular release to form the RNA-induced silencing complex (RISC)48. The endosomal 
escape process and triggering the intracellular release tend to be the most important factors when developing 
effective siRNA delivery tools and are still not well understood for engineered  nanomaterials49. Here, we decided 
to test the ability of our fullerene nanomaterials to silence the GFP fluorescence signal using a prostate cancer 
cell line (DU145) due to the simplicity of the  model26. To better mimic in vivo conditions, we conducted all of 
the siRNA transfection experiments in the presence of FBS.
The R value (70) that used in the transfection experiments was calculated by dividing the nitrogen-to-phos-
phorus (N/P) ratio by two. Interestingly, due to the many positive charges placed at the nitrogen atoms in our two 
fullerene nanomaterials  HexakisaminoC60 and JK39 (24 and 20, respectively), the R number was also high—the 
experimental values of the R parameter that were used for the siRNA transfection with the TPFE fullerene was 
between 20 and 50. Interestingly, in the transfection experiments carried out using the TPFE fullerene, it was 
dissolved in a potassium chloride solution (pH 2) to ensure the complete protonation of the aminofullerene 
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core before the formation of complex with desired siRNA. In our experiments two fullerene nanomaterials were 
dissolved in nuclease free water (pH 7) without adding any buffers—the low pH of that solution could have 
cytotoxic effects on the cells.
Our next step was the physicochemical characterization of the fullerene-siRNA complexes. Firstly, 
we studied the changes in the zeta potential of the formed complexes, assuming that it would decrease due 
to the anionic character of the RNA phosphate groups. As is depicted in Fig. 3C, the zeta potential of the 
 HexakisaminoC60-siRNA complex was + 19.1 mV (a change from + 28.6 mV), while the JK39-siRNA complex also 
had a higher zeta potential, measured at + 32.7 mV—a change from + 54 and + 90 mV (Fig. 3D). Simultaneously, 
the  HexakisaminoC60-siRNA complex formed monodisperse aggregates (PDI = 0.29) around 361 nm, whereas 
the JK39-siRNA complex had a polydisperse mixture of aggregates around 110, 604, and 4230 nm with PDI > 0.6. 
The observations mentioned above regarding the size of the siRNA complexes were further investigated with 
TEM morphology measurements, which revealed that was a fluffy-like structure (Fig. 3A) and polydispersity for 
the JK39-siRNA complex (Fig. 3B) and an image of the  HexakisaminoC60-siRNA complex which is presented in 
Fig. S8. The previously published reports by Nakamura et al. that described the TPFE–siRNA–plasma protein 
complex interactions revealed that it can disintegrate on a solid substrate, which suggests that it would also be 
unstable in vivo for releasing  siRNA11.
Figure 2.  (A) Infrared spectrum of fullerene JK39; (B) ESI-mass spectrum of water-soluble fullerene JK39 
(positive mode, 100 mV); (C) A high-resolution photoemission spectra of carbon and nitrogen measured in the 
fullerene nanomaterials JK39 and  HexakisaminoC60.
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Our final experiment was to test the siRNA transfection efficacy of the created highly water-soluble fullerene 
nanomaterials on prostate cancer cells that had been transfected with the EGFP-encoding plasmid and to com-
pare their transfection properties in the presence of a serum with lipid-based Lipofectamine 3000 being used as 
a positive control. The results are depicted in Fig. 4, which shows a significant decrease in the fluorescence signal 
(to around 50%) when the cells were treated with the  HexakisaminoC60-siRNA complex. Notably, the fullerene 
nanomaterial JK39 had quite a low transfections efficacy. Based on the zeta potential measurements and TEM 
Figure 3.  The TEM images of the siRNA-fullerene complexes that were measured for (A)  HexakisaminoC60 
and (B) JK39 carbon nanomaterials; (C,D) zeta potentials of the siRNA-fullerene complexes that were measured 
for C-HexakisaminoC60 and D-JK39 carbon nanomaterials.
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analysis, we suspect that JK39 forms an extremely stable complex with siRNA delivering it to the cytosol but that 
it cannot cleave it in cellular conditions. These effects could also be caused by the d-glucosamine moiety, which 
has an additional nitrogen connected at C2 position of glucosamine, which could be additionally protonated 
(as TFA salt) and that the differences in protein corona adsorbed on the surface of fullerene nanomaterials-
JK39 possess additional sugar based hydroxyl groups. This explanation complies with the higher zeta potential 
of sugar-based JK39 complex and thus its higher stability within cells. Moreover siRNA, when used without 
adding of any transfection agent, works better; it decreases the GFP fluorescence signal to 75 percent of the 
starting signal, which further confirms our hypothesis. An attractive option for future biological studies of the 
JK39 fullerene nanomaterial could be to test the photocleavage of the JK39-siRNA stable complex based on the 
irradiation of cells with blue/green light (glycofullerenes are photosensitizers) and the generation of ROS, which 
led to good results for the  C60-Dex-NH2 fullerene and the upconversion nanomaterials that were used as the 
siRNA transfection  agents13,50.
Conclusions
In summary, inspired by a previously developed TPFE cationic fullerene transfection agent, we developed two 
cationic fullerenes  HexakisaminoC60 and monoglucosamine JK39, which had a  Th symmetry that is character-
istic for Bingel–Hirsch hexakisadducts. To the best of our knowledge, this is the first example of [60]fullerene 
hexakisadduct being ready to transfect siRNA. We postulate that the inactivity of JK39 fullerene in transfection 
experiments is caused by its high initial zeta potential and polydispersity. Future biological experiments should 
also determine how JK39 protects siRNA against enzymatic degradation, mainly by analyzing the adsorbed serum 
proteins (protein corona) on its surface. The cationic water-soluble fullerene nanomaterials to which adding 
interesting groups and tags (as sugars, azides or triple bonds for biorthogonal chemistry) can be attached, might 
hold considerable promise for in vivo siRNA delivery in the future.
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